Price target
15.500.000.00%
The 3 analysts offering 1 year price forecasts for NP5 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to NP5 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NP5 EPS for the last quarter is EUR despite the estimation of −0.41 EUR. In the next quarter EPS is expected to reach −1.38 EUR. Track more of Newron Pharmaceuticals S.p.A. financials and stay on top of what is up with the company.
In the next quarter Newron Pharmaceuticals S.p.A. revenue is expected to reach 3.60 M EUR. Check out Newron Pharmaceuticals S.p.A. revenue and earnings and make informed decisions.
According to analysts, NP5 price target is 15.50 EUR with a max estimate of 21.85 EUR and a min estimate of 12.32 EUR. Check if this forecast comes true in a year, meanwhile watch Newron Pharmaceuticals S.p.A. stock price chart and keep track of the current situation with NP5 news and stock market news.